Cargando…

Targeting AP-1 transcription factors by CRISPR in the prostate

Prostate cancer is the second most diagnosed cancer in men. It is a slow progressing cancer, but when the disease reaches an advanced stage, treatment options are limited. Sequencing analyses of cancer samples have identified genes that can potentially drive disease progression. We implemented the C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riedel, Maria, Cai, Huiqiang, Stoltze, Iben C., Vendelbo, Mikkel H., Wagner, Erwin F., Bakiri, Latifa, Thomsen, Martin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448511/ https://www.ncbi.nlm.nih.gov/pubmed/34548912 http://dx.doi.org/10.18632/oncotarget.27997

Ejemplares similares

In vivo CRISPR inactivation of Fospromotes prostate cancer progression by altering the associated AP-1 subunit Jun
por: Riedel, Maria, et al.
Publicado: (2021)

A FATal AP-1 dimer switch in hepatosteatosis
por: Bakiri, Latifa, et al.
Publicado: (2014)

Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production
por: Bozec, Aline, et al.
Publicado: (2010)

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
por: Marques, Carolina, et al.
Publicado: (2021)

News and views on EMT Fra-1 controls EMT in mammary epithelial cells
por: Bakiri, Latifa, et al.
Publicado: (2015)

Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2
por: Wurm, Stefanie, et al.
Publicado: (2015)

The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues
por: Berthelsen, Martin Fogtmann, et al.
Publicado: (2021)

In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial Plasticity
por: Cai, Huiqiang, et al.
Publicado: (2022)

Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9
por: Berthelsen, Martin F., et al.
Publicado: (2021)

Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)

Comprehensive mandatory policies are needed to fully protect all children from unhealthy food marketing
por: Dillman Carpentier, Francesca R., et al.
Publicado: (2023)

JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells
por: Gurzov, Esteban N., et al.
Publicado: (2008)

Open Thy Lattice Osteoclast, Resorb me!
por: Bakiri, Latifa
Publicado: (2023)

Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells
por: Novoszel, Philipp, et al.
Publicado: (2021)

The novel mitochondria-targeted hydrogen sulfide (H(2)S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro
por: Gerő, Domokos, et al.
Publicado: (2016)

Current Bioinformatics Tools to Optimize CRISPR/Cas9 Experiments to Reduce Off-Target Effects
por: Naeem, Muhammad, et al.
Publicado: (2023)

Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation
por: Bakiri, Latifa, et al.
Publicado: (2017)

Enabling the Rise of a CRISPR World
por: LaManna, Caroline M., et al.
Publicado: (2018)

CRISPR-Cas Technology In and Out of the Classroom
por: Dahlberg, Lina, et al.
Publicado: (2018)

The AP-1 Transcription Factor c-Jun Prevents Stress-Imposed Maladaptive Remodeling of the Heart
por: Windak, Renata, et al.
Publicado: (2013)

Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis
por: Matsuoka, Kazuhiko, et al.
Publicado: (2023)

Too Much Compromise in Today's CRISPR Pipelines
por: Fox, Richard
Publicado: (2019)

Do CRISPR Germline Ethics Statements Cut It?
por: Brokowski, Carolyn
Publicado: (2018)

CRISPR Technology: A Jewish Legal Perspective
por: Loike, John D., et al.
Publicado: (2022)

Transcription factors promote neural regeneration after spinal cord injury
por: Finkel, Zachary, et al.
Publicado: (2022)

CRISPR/Cas9 and TALE: beyond cut and paste
por: Deng, Liping, et al.
Publicado: (2015)

CRISPR-Guided Proximity Labeling of RNA–Protein Interactions
por: Lu, Mingxing, et al.
Publicado: (2022)

The Promise of CRISPR for Human Germline Editing and the Perils of “Playing God”
por: Locke, Larry G.
Publicado: (2020)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

TPL-2 Inhibits IFN-β Expression via an ERK1/2-TCF-FOS Axis in TLR4-Stimulated Macrophages
por: Blair, Louise, et al.
Publicado: (2022)

Challenges of Decoding Transcription Factor Dynamics in Terms of Gene Regulation
por: Martin, Erik W., et al.
Publicado: (2018)

Normal and pathological bone development controlled by the AP-1 transcription factor complex
por: Wagner, EF
Publicado: (2001)

The AP-2 family of transcription factors
por: Eckert, Dawid, et al.
Publicado: (2005)

Genome-Wide Identification of the Target Genes of AP2-O, a Plasmodium AP2-Family Transcription Factor
por: Kaneko, Izumi, et al.
Publicado: (2015)

The AP-1 transcription factors c-Jun and JunB are essential for CD8α conventional dendritic cell identity
por: Novoszel, Philipp, et al.
Publicado: (2021)

CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy
por: Amendola, Mario, et al.
Publicado: (2022)

Chemically targeting the redox switch in AP1 transcription factor ΔFOSB
por: Kumar, Ashwani, et al.
Publicado: (2022)

A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 use
por: Jiang, Long, et al.
Publicado: (2022)

PPAR-γ: a thrifty transcription factor
por: Auwerx, Johan, et al.
Publicado: (2003)

Onecut transcription factors in retinal development and maintenance
por: Sapkota, Darshan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_15mtv10oh82qdsskh0vhijvr3q